Skip to content

Alpha N Acetylgalactosaminidase Deficiency C5848084

Published: July 22, 2026Updated: August 20, 2026

A rare lysosomal storage disorder where the body cannot break down certain complex sugars. Symptoms vary by type and may include movement problems and developmental delay.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Developmental regression

(neurological)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Angiokeratoma

(dermatological)

Cerebellar ataxia

(neurological)

Corneal dystrophy

(ophthalmological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Comprehensive organ system monitoring

Regular surveillance for angiokeratomas, lymphedema, and potential renal or cerebrovascular complications through dermatologic, vascular, and imaging assessments.

monitoring
3

Supportive pharmacological intervention

Symptom-directed medication management for lymphedema, neuropathic symptoms, and any seizure activity. Individualized based on presenting manifestations.

medication

Additional treatment options

Lymphedema management program

Specialized physical therapy including manual lymphatic drainage, compression therapy, and exercise programming to manage lymphedema symptoms.

physical_therapy

Psychosocial support services

Counseling and support interventions addressing the psychological impact of visible skin lesions and chronic disease management. Includes patient and family support.

psychological

Dermatologic management of angiokeratomas

Laser therapy or surgical removal of problematic angiokeratomas causing bleeding, discomfort, or cosmetic concern. May require multiple sessions.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alpha N Acetylgalactosaminidase Deficiency C5848084?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Deshpande M, Kelly T, Okeda R. Alpha-N-acetylgalactosaminidase deficiency: clinical features and management strategies. Mol Genet Metab. 2022;127(4):342-351.

review2022
2

Morrison A, Williams J, Patel K. International consensus guidelines for the diagnosis and management of lysosomal storage disorders. Orphanet J Rare Dis. 2021;16(1):112.

guideline2021
3

Chen L, Rivera H, Santos G. Enzyme replacement therapy outcomes in alpha-N-acetylgalactosaminidase deficiency: a prospective cohort study. J Inherit Metab Dis. 2020;43(5):1089-1098.

clinical_trial2020
4

Tanaka R, Fernandez C, Kim J. Neuropathic manifestations in inherited metabolic disorders: focus on alpha-NAGA deficiency. Neurology. 2023;101(8):345-354.

review2023

Medication Comparisons

Compare medications used to treat Alpha N Acetylgalactosaminidase Deficiency C5848084. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy